Leveraging Network Pharmacology and Molecular Docking to Discover Novel Multitarget Antidepressants
Journal of Computational Biophysics and Chemistry · 21.08.2026 · 1-23
DOI: 10.1142/s2737416526300026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computational Biophysics and Chemistry, online erschienen am 21.08.2026. Verfasst von Dhananjay Joshi und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Depression, or Major Depressive Disorder (MDD), is linked to suicidal tendencies and is becoming increasingly common, making it a critical mental health issue that requires attention. The rise in its prevalence is attributed to significant lifestyle and environmental shifts. Although traditional antidepressants that target monoaminergic systems are available, they face challenges such as delayed effects, side effects, and Treatment-Resistant Depression (TRD), due to their limited mechanisms of action, inconsistent response rates, and the complex nature of depression. Recent studies indicate that MDD involves intricate neurobiological processes, including dysregulation of the Hypothalamic Pituitary Adrenal Axis (HPA), neuroinflammation, oxidative stress, and neurotransmitter imbalances. In recent years, advancements in bioinformatics, combined with Network Pharmacology (NP), molecular docking, and Computer-Aided Drug Design (CADD), have offered a comprehensive platform for discovering and validating new antidepressant candidates with multitarget effects. These in silico tools enable the elucidation of compound target pathway networks, facilitate virtual screening, and accelerate the optimization of lead molecules, particularly from natural sources, such as medicinal plants. Phytoconstituents, such as flavonoids and alkaloids, exhibit promising antidepressant potential through modulation of key pathways including PI3K/Akt, MAPK, cAMP/CREB, and HIF-1[Formula: see text]–VEGF. This review aims to provide the information obtained from the above mentioned in silico tools to identify appropriate targets and novel antidepressants, aiming to improve the safety and efficacy of existing drugs and develop new therapies from ethnobotanicals by exploring multitarget approaches.
Zitieren
APA
Joshi, D., Aswar, U., Ganeshpurkar, A., & Rathod, K. (2026). Leveraging Network Pharmacology and Molecular Docking to Discover Novel Multitarget Antidepressants. Journal of Computational Biophysics and Chemistry, 1-23. https://doi.org/10.1142/s2737416526300026
Vancouver
Joshi D, Aswar U, Ganeshpurkar A, Rathod K. Leveraging Network Pharmacology and Molecular Docking to Discover Novel Multitarget Antidepressants. Journal of Computational Biophysics and Chemistry. 2026:1-23. doi:10.1142/s2737416526300026
BibTeX
@article{Joshi2026,
author = {Joshi, Dhananjay and Aswar, Urmila and Ganeshpurkar, Ankit and Rathod, Kundlik},
title = {Leveraging Network Pharmacology and Molecular Docking to Discover Novel Multitarget Antidepressants},
journal = {Journal of Computational Biophysics and Chemistry},
year = {2026},
pages = {1--23},
doi = {10.1142/s2737416526300026}
}
EUVIMED